Heartseed株式会社 Logo

Heartseed株式会社

Clinical-stage biotech developing regenerative medicine for severe heart failure.

219A | T

Overview

Corporate Details

ISIN(s):
JP3765140003
LEI:
Country:
Japan
Address:
港区芝浦1丁目2番3号シーバンスS館5階

Description

Heartseed Inc. is a clinical-stage biotechnology company pioneering regenerative medicine for severe heart failure. The company's core technology involves the creation of high-purity cardiomyocytes (heart muscle cells) from induced pluripotent stem cells (iPS cells) to achieve cardiac 'remuscularization.' Its lead pipeline candidate, HS-001, is an allogeneic iPS cell-derived cardiomyocyte therapy administered via intramyocardial injection. This treatment is being developed for patients with heart failure with reduced ejection fraction (HFrEF), including those with dilated cardiomyopathy or old myocardial infarction, offering a potential alternative to heart transplantation. Heartseed is also advancing next-generation research using autologous and HLA-edited iPS cells to improve treatment outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-06-19 09:00
臨時報告書
Japanese ZIP 19.9 KB
2025-06-12 08:30
確認書
Japanese ZIP 8.0 KB
2025-06-12 08:30
半期報告書-第10期(2024/11/01-2025/12/31)
Japanese ZIP 143.9 KB
2025-01-27 02:01
臨時報告書
Japanese ZIP 21.3 KB
2025-01-27 02:01
確認書
Japanese ZIP 8.0 KB
2025-01-27 02:00
有価証券報告書-第9期(2023/11/01-2024/10/31)
Japanese ZIP 6.0 MB
2025-01-27 02:00
内部統制報告書-第9期(2023/11/01-2024/10/31)
Japanese ZIP 21.1 KB
2024-07-22 08:18
訂正有価証券届出書(新規公開時)
Japanese ZIP 4.6 MB
2024-07-11 08:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 4.6 MB
2024-06-26 08:00
有価証券届出書(新規公開時)
Japanese ZIP 9.0 MB

Automate Your Workflow. Get a real-time feed of all Heartseed株式会社 filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Heartseed株式会社

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Heartseed株式会社 via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.